AIMS: Circulating endothelium-derived extracellular vesicles (EV) levels are altered in pulmonary arterial hypertension (PAH) but whether they are biomarkers of cellular injury or participants in disease pathogenesis is unknown. Previously, we found that lung-derived EVs (LEVs) induce bone marrow-derived progenitor cells to express lung-specific mRNA and protein. In this study, we sought to determine whether LEV or plasma-derived EV (PEV) alter pulmonary vascular endothelial or marrow progenitor cell phenotype to induce pulmonary vascular remodelling. METHODS AND RESULTS: LEV, PEV isolated from monocrotaline (MCT-EV)- or vehicle-treated mice (vehicle-EV) were injected into healthy mice. Right ventricular (RV) hypertrophy and pulmonary vascular remodelling were assessed by RV-to-body weight (RV/BW) and blood vessel wall thickness-to-diameter (WT/D) ratios. RV/BW, WT/D ratios were elevated in MCT- vs. vehicle-injected mice (1.99 ± 0.09 vs. 1.04 ± 0.09 mg/g; 0.159 ± 0.002 vs. 0.062 ± 0.009%). RV/BW, WT/D ratios were higher in mice injected with MCT-EV vs. mice injected with vehicle-EV (1.63 ± 0.09 vs. 1.08 ± 0.09 mg/g; 0.113 ± 0.02 vs. 0.056 ± 0.01%). Lineage-depleted bone marrow cells incubated with MCT-EV and marrow cells isolated from mice infused with MCT-EV had greater expression of endothelial progenitor cell mRNAs and mRNAs abnormally expressed in PAH than cells incubated with vehicle-EV or isolated from vehicle-EV infused mice. MCT-EV induced an apoptosis-resistant phenotype in murine pulmonary endothelial cells and lineage-depleted bone marrow cells incubated with MCT-EV induced pulmonary hypertension when injected into healthy mice. CONCLUSIONS: EV from MCT-injured mice contribute to the development of MCT-induced pulmonary hypertension. This effect may be mediated directly by EV on the pulmonary vasculature or by differentiation of bone marrow cells to endothelial progenitor cells that induce pulmonary vascular remodelling.
AIMS: Circulating endothelium-derived extracellular vesicles (EV) levels are altered in pulmonary arterial hypertension (PAH) but whether they are biomarkers of cellular injury or participants in disease pathogenesis is unknown. Previously, we found that lung-derived EVs (LEVs) induce bone marrow-derived progenitor cells to express lung-specific mRNA and protein. In this study, we sought to determine whether LEV or plasma-derived EV (PEV) alter pulmonary vascular endothelial or marrow progenitor cell phenotype to induce pulmonary vascular remodelling. METHODS AND RESULTS: LEV, PEV isolated from monocrotaline (MCT-EV)- or vehicle-treated mice (vehicle-EV) were injected into healthy mice. Right ventricular (RV) hypertrophy and pulmonary vascular remodelling were assessed by RV-to-body weight (RV/BW) and blood vessel wall thickness-to-diameter (WT/D) ratios. RV/BW, WT/D ratios were elevated in MCT- vs. vehicle-injected mice (1.99 ± 0.09 vs. 1.04 ± 0.09 mg/g; 0.159 ± 0.002 vs. 0.062 ± 0.009%). RV/BW, WT/D ratios were higher in mice injected with MCT-EV vs. mice injected with vehicle-EV (1.63 ± 0.09 vs. 1.08 ± 0.09 mg/g; 0.113 ± 0.02 vs. 0.056 ± 0.01%). Lineage-depleted bone marrow cells incubated with MCT-EV and marrow cells isolated from mice infused with MCT-EV had greater expression of endothelial progenitor cell mRNAs and mRNAs abnormally expressed in PAH than cells incubated with vehicle-EV or isolated from vehicle-EV infused mice. MCT-EV induced an apoptosis-resistant phenotype in murine pulmonary endothelial cells and lineage-depleted bone marrow cells incubated with MCT-EV induced pulmonary hypertension when injected into healthy mice. CONCLUSIONS: EV from MCT-injured mice contribute to the development of MCT-induced pulmonary hypertension. This effect may be mediated directly by EV on the pulmonary vasculature or by differentiation of bone marrow cells to endothelial progenitor cells that induce pulmonary vascular remodelling.
Entities:
Keywords:
Bone marrow stem/progenitor cells; Endothelium; Microparticles; Monocrotaline; Pulmonary hypertension
Authors: D M Smadja; L Mauge; O Sanchez; J-S Silvestre; C Guerin; A Godier; P Henno; P Gaussem; D Israël-Biet Journal: Eur Respir J Date: 2010-04-22 Impact factor: 16.671
Authors: Nicolas Amabile; Christian Heiss; Vivian Chang; Franca S Angeli; Lauren Damon; Eddie J Rame; Dana McGlothlin; William Grossman; Teresa De Marco; Yerem Yeghiazarians Journal: J Heart Lung Transplant Date: 2009-10 Impact factor: 10.247
Authors: Prue N Plummer; Ruth Freeman; Ryan J Taft; Jelena Vider; Michael Sax; Brittany A Umer; Dingcheng Gao; Christopher Johns; John S Mattick; Stephen D Wilton; Vito Ferro; Nigel A J McMillan; Alexander Swarbrick; Vivek Mittal; Albert S Mellick Journal: Cancer Res Date: 2012-07-25 Impact factor: 12.701
Authors: Kewal Asosingh; Micheala A Aldred; Amit Vasanji; Judith Drazba; Jacqueline Sharp; Carol Farver; Suzy A A Comhair; Weiling Xu; Lauren Licina; Lan Huang; Bela Anand-Apte; Mervin C Yoder; Rubin M Tuder; Serpil C Erzurum Journal: Am J Pathol Date: 2008-02-07 Impact factor: 4.307
Authors: Joshua P Fessel; Rizwan Hamid; Bryan M Wittmann; Linda J Robinson; Tom Blackwell; Yuji Tada; Nobuhiro Tanabe; Koichiro Tatsumi; Anna R Hemnes; James D West Journal: Pulm Circ Date: 2012 Apr-Jun Impact factor: 3.017
Authors: Matthew R Lammi; Lesley Ann Saketkoo; Samuel C Okpechi; Mohamed A Ghonim; Dorota Wyczechowska; Natalie Bauer; Kusma Pyakurel; Saito Saito; Bennett P deBoisblanc; A Hamid Boulares Journal: Respirology Date: 2019-02-12 Impact factor: 6.424
Authors: Peter J Quesenberry; Laura R Goldberg; Jason M Aliotta; Mark S Dooner; Mandy G Pereira; Sicheng Wen; Giovanni Camussi Journal: Stem Cells Dev Date: 2014-04-01 Impact factor: 3.272
Authors: Ke Yuan; Elya A Shamskhou; Mark E Orcholski; Abinaya Nathan; Sushma Reddy; Hiroaki Honda; Vigneshwaran Mani; Yitian Zeng; Mehmet O Ozen; Lingli Wang; Utkan Demirci; Wen Tian; Mark R Nicolls; Vinicio A de Jesus Perez Journal: Circulation Date: 2019-04-02 Impact factor: 29.690
Authors: Jason M Aliotta; Mandy Pereira; Sicheng Wen; Mark S Dooner; Michael Del Tatto; Elaine Papa; Laura R Goldberg; Grayson L Baird; Corey E Ventetuolo; Peter J Quesenberry; James R Klinger Journal: Cardiovasc Res Date: 2016-03-14 Impact factor: 10.787
Authors: Olin D Liang; Eui-Young So; Pamela C Egan; Laura R Goldberg; Jason M Aliotta; Keith Q Wu; Patrycja M Dubielecka; Corey E Ventetuolo; Anthony M Reginato; Peter J Quesenberry; James R Klinger Journal: Cardiovasc Res Date: 2017-11-01 Impact factor: 10.787